Clinical trial
Diagnostic Outcome Trial in Heart Failure (DOT-HF Trial)
NCT00480077 · Medtronic Cardiac Rhythm and Heart Failure, Industry · Terminated
Key facts
| NCT number | NCT00480077 |
|---|---|
| Title | Diagnostic Outcome Trial in Heart Failure (DOT-HF Trial) |
| Official title | Diagnostic Outcome Trial in Heart Failure |
| Acronym | DOT-HF |
| Lead sponsor | Medtronic Cardiac Rhythm and Heart Failure, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Device |
| Interventions | Programming (CRT-D, ICD OptiVol® and Cardiac Compass® ) |
| Enrollment | 335 |
| Start date | Mar 1, 2007 |
| Primary completion | Jan 1, 2011 |
| Completion | Jan 1, 2011 |
| First posted | May 30, 2007 |
| Last update posted | Jul 2, 2025 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: